Sanofi and Bristol-Myers Squibb announce restructuring of alliance agreement
3 October 2012 | By Bristol-Myers Squibb Company
Sanofi & Bristol-Myers Squibb have restructured their long-term alliance...
List view / Grid view
3 October 2012 | By Bristol-Myers Squibb Company
Sanofi & Bristol-Myers Squibb have restructured their long-term alliance...
1 October 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Dr. Paul Chew...
20 September 2012 | By Sanofi
Sanofi and TB Alliance have announced a new research collaboration agreement...
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
13 August 2012 | By Sanofi
Breakthrough device design talks patients and caregivers through the injection process...
20 July 2012 | By Sanofi
ODYSSEY will comprise over 10 clinical trials...
18 July 2012 | By Sanofi
Ataxia UK, Crohn’s & Colitis UK & Muscular Dystrophy Campaign share £50,000 to help better the lives of patients throughout the UK...
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
19 June 2012 | By Sanofi
Sanofi and the Joslin Diabetes Center announced a new collaboration...
13 June 2012 | By Sanofi
Sanofi granted the award for “Leading Pan-European Quoted Company for Investor Relations”...
12 June 2012 | By Sanofi
Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...
11 June 2012 | By Sanofi
New results of a large-scale epidemiological program announced...
11 June 2012 | By Sanofi
Sanofi announced that the marketing authorization application for Lyxumia®...